Healthcare and Medical Device

The Antibody Drug Conjugates (ADC) industry represents a cutting-edge and rapidly evolving sector within the field of biopharmaceuticals. ADCs are a class of targeted cancer therapies that combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs, delivering highly targeted treatment to cancer cells while sparing healthy tissue. Over recent years, the ADC industry has witnessed substantial growth, driven by advancements in antibody engineering, linker technology, and payload selection, resulting in a robust pipeline of promising ADC candidates across various cancer types. With several ADCs already approved by regulatory agencies and many more in clinical development, the industry holds significant promise for improving the treatment landscape for cancer patients, offering the potential for enhanced efficacy and reduced side effects compared to traditional chemotherapy. As research and development efforts continue to expand, the ADC industry is poised to make ...

Softgel Capsules Market in terms of revenue was estimated to be worth $1.1 billion in 2023 and is poised to reach $1.5 billion by 2028, growing at a CAGR of 6.3% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by the benefits of softgel capsules, increasing demand for dietary supplements and nutraceuticals, and rising demand for naturally sourced ingredients. The softgel capsules industry is poised for significant growth in the next five years. With an increasing emphasis on health and wellness, coupled with advancements in pharmaceutical and nutraceutical formulations, the demand for softgel capsules is projected to surge. These versatile, easy-to-swallow dosage forms offer advantages such as improved bioavailability and precise dosing, making them appealing to both consumers and manufacturers. Furthermore, the expanding market for CBD and cannabis-based products, along with the rising aging population seeking convenien...